Fate therapeutics inc (FATE)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Dec'12
Assets
Current assets:
Cash and cash equivalents

83,366

99,814

249,588

71,435

183,033

190,514

183,247

36,162

32,912

88,952

43,231

31,063

40,608

88,609

37,099

35,870

39,487

64,809

72,857

81,176

42,349

49,101

45,530

42,012

47,881

54,036

19,082

9,087

Accounts receivable

-

-

-

-

500

500

500

-

500

-

-

-

-

-

-

-

-

-

846

-

-

-

-

-

-

-

-

-

Short-term investments and related maturity receivables

119,918

121,613

53,235

90,573

-

10,493

27,945

41,857

55,722

11,997

25,983

39,950

41,692

3,503

9,520

10,060

16,125

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

4,965

5,662

2,810

3,170

2,897

3,689

2,237

2,015

1,491

1,647

825

848

1,137

1,211

780

1,162

955

843

482

395

443

760

94

233

382

615

304

706

Total current assets

208,249

227,089

305,633

165,178

186,430

205,196

213,929

80,034

90,625

102,596

70,039

71,861

83,437

93,323

47,399

47,092

56,567

65,652

74,185

81,571

42,792

49,861

45,624

42,245

48,263

54,651

19,386

9,793

Long-term investments

16,139

39,440

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

11,896

11,419

9,653

9,225

8,402

5,125

3,798

2,894

2,649

2,550

2,490

1,945

1,746

1,579

1,750

1,940

1,992

2,160

2,072

1,766

1,544

1,200

1,240

1,159

1,264

810

789

1,161

Operating lease right-of-use assets

69,200

22,752

23,160

23,560

23,955

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

15,227

227

227

227

227

227

227

227

122

122

122

122

122

122

122

122

122

122

122

122

122

122

122

122

122

122

122

122

Collaboration contract asset

1,170

1,338

1,525

1,687

1,851

1,958

2,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

9

9

9

-

-

526

-

-

24

24

24

24

24

24

24

24

24

24

24

24

32

-

24

25

-

-

2,743

-

Total assets

321,890

302,274

340,207

199,877

220,865

213,032

219,954

83,155

93,420

105,292

72,675

73,952

85,329

95,048

49,295

49,178

58,705

67,958

76,403

83,483

44,490

51,183

47,010

43,551

49,649

55,583

23,040

11,076

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

5,173

5,822

5,715

5,410

5,367

4,205

5,236

3,510

2,160

1,678

2,198

1,177

2,470

934

1,200

1,998

1,975

996

1,280

1,507

1,271

645

1,157

980

1,330

682

-

1,228

Accrued expenses

11,770

14,697

13,843

9,834

9,950

10,926

9,638

8,376

7,440

7,254

5,413

4,769

4,699

3,957

3,343

2,355

2,038

2,439

2,317

2,491

1,827

2,260

2,010

1,948

1,641

2,039

-

1,040

CIRM award liability, current portion

3,160

2,808

2,106

2,106

2,106

2,106

1,284

600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of deferred rent

-

-

-

-

-

-

-

-

125

12

-

1

3

4

5

5

63

54

45

35

26

85

77

69

61

53

45

251

Deferred revenue, current portion

2,923

2,787

3,367

5,049

6,576

7,588

3,250

1,776

2,105

2,105

2,105

2,105

2,105

2,105

2,105

2,105

2,105

2,401

2,451

2,105

-

-

-

-

-

-

-

63

Operating lease liabilities, current portion

1,898

1,692

1,632

1,572

1,200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,725

-

Convertible notes, net of discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,481

-

Repurchase liability for unvested equity awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

9

21

33

45

57

69

82

94

106

143

Preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

163

184

Long-term debt, current portion

-

-

13,932

5,447

3,941

2,438

3,264

2,011

758

-

-

-

7,620

8,187

8,025

7,864

7,705

7,550

6,494

5,156

3,256

1,535

611

746

1,240

1,732

1,971

1,941

Total current liabilities

24,924

27,806

40,595

29,418

29,140

27,263

22,672

16,273

12,588

11,049

9,716

8,052

16,897

15,187

14,678

14,327

13,886

13,441

12,596

11,315

6,413

4,570

3,912

3,812

4,354

4,600

9,491

4,850

Deferred rent

-

-

-

-

-

3,401

2,441

1,462

1,303

1,347

1,090

821

543

101

99

97

42

58

75

91

100

51

76

101

118

135

153

132

Accrued expenses

-

-

-

718

629

549

455

360

267

175

81

1,414

647

1,276

1,180

1,068

942

799

642

478

312

149

57

-

-

-

137

110

Deferred revenue, net of current portion

3,124

3,775

4,496

5,244

6,380

7,500

8,000

-

198

724

1,250

1,776

2,303

2,829

3,355

3,881

4,408

4,934

5,460

5,986

-

-

-

-

-

-

-

-

CIRM award liability, net of current portion

790

702

1,404

1,404

1,404

1,404

856

400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, net of current portion

73,834

25,235

25,670

26,098

26,517

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Exchangeable share liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,885

551

Long-term debt, net of current portion

-

-

-

9,469

10,958

12,446

11,601

12,835

14,069

14,808

14,789

6,676

1,081

2,501

4,610

6,676

8,700

10,688

12,635

14,539

16,414

18,073

9,389

-

-

-

250

1,732

Long-term convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20,000

-

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Convertible Preferred Stock, $0.001 par value; authorized shares - zero at December 31, 2013 and 62,200,000 at December 31, 2012; issued and outstanding shares - zero at December 31, 2013 and 44,967,690 at December 31, 2012

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

56,526

56,526

Stockholders’ equity:
Preferred stock, $0.001 par value; authorized shares—5,000,000 at March 31, 2020 and December 31, 2019; Class A Convertible Preferred shares issued and outstanding—2,794,549 at March 31, 2020 and December 31, 2019

3

3

3

3

3

3

3

3

3

3

3

3

3

3

0

0

0

-

0

0

0

0

0

0

0

0

-

0

Common stock, $0.001 par value; authorized shares—150,000,000 at March 31, 2020 and December 31, 2019; issued and outstanding—75,996,075 at March 31, 2020 and 75,730,260 at December 31, 2019

76

76

75

65

65

65

65

53

53

53

41

41

41

41

34

29

29

29

29

29

21

21

21

21

20

20

1

1

Additional paid-in capital

636,062

628,200

623,156

455,999

450,925

445,799

443,244

304,371

297,885

295,934

252,019

250,825

249,820

248,957

193,242

182,258

181,445

180,393

179,904

179,097

141,503

140,711

139,714

139,173

138,646

137,337

14,367

12,789

Accumulated other comprehensive gain

142

22

51

93

-

-2

-14

-15

-13

-3

-13

-39

-34

-1

3

11

14

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-417,065

-383,545

-355,243

-328,634

-305,156

-285,396

-269,369

-252,587

-232,933

-218,798

-206,301

-195,617

-185,972

-175,846

-167,906

-159,169

-150,761

-142,384

-134,938

-128,052

-120,273

-112,392

-106,159

-99,556

93,489

-86,509

80,770

65,615

Total stockholders’ equity

219,218

244,756

268,042

127,526

145,837

160,469

173,929

51,825

64,995

77,189

45,749

55,213

63,858

73,154

25,373

23,129

30,727

38,038

44,995

51,074

21,251

28,340

33,576

39,638

45,177

50,848

-66,402

-52,825

Total liabilities and stockholders’ equity

321,890

302,274

340,207

199,877

220,865

213,032

219,954

83,155

93,420

105,292

72,675

73,952

85,329

95,048

49,295

49,178

58,705

67,958

76,403

83,483

44,490

51,183

47,010

43,551

49,649

55,583

23,040

11,076